慢性阻塞性肺疾病与相关生物标志物研究进展
Research Progress on Chronic Obstructive Pulmonary Disease and Related Biomarkers
DOI: 10.12677/jcpm.2024.34182, PDF,    科研立项经费支持
作者: 王乌云：内蒙古民族大学临床医学院，内蒙古 通辽；毛广泽：扎鲁特旗人民医院呼吸科，内蒙古 通辽；佟淑平*：内蒙古民族大学附属医院呼吸内科，内蒙古 通辽
关键词: 慢性阻塞性肺疾病；慢性阻塞性肺疾病急性加重期；CRP；降钙素原；HDAC-2；CP-D；Chronic Obstructive Pulmonary Disease； Acute Exacerbation of Chronic Obstructive Pulmonary Disease； CRP； Procalcitonin； HDAC-2； CP-D
摘要: 作为一种具有高发病率、高死亡率特点的呼吸系统疾病，慢阻肺不仅给患者带来巨大负担，对全球卫生系统而言也是一个巨大挑战。在多种机制的参与下的反复急性加重是慢阻肺患者死亡的原因之一。据统计，约50%的急性加重事件并未报告。频繁的急性加重是慢阻肺全因死亡的独立危险因素，慢阻肺患者一次急性加重入院其5年死亡率为55.2%，两次中重度急性加重，其死亡风险增加至80%。目前慢阻肺急性加重期的诊断及其严重程度的判定缺乏具体的量化性指标，主要依据患者的症状、体征和医生的判断，故感染性炎性标志物对于AECOPD的诊断和治疗至关重要。该文对近年来关于COPD生物标志物的研究进行了综述。
Abstract: As a respiratory disease with high incidence rate and mortality, COPD not only brings huge burden to patients, but also poses a huge challenge to the global health system. Repeated acute exacerbations involving multiple mechanisms are one of the causes of death in patients with chronic obstructive pulmonary disease. According to statistics, about 50% of acute exacerbations are not reported. Frequent acute exacerbations are an independent risk factor for all-cause mortality in patients with chronic obstructive pulmonary disease (COPD). A 5-year mortality rate of 55.2% for COPD patients admitted to the hospital with one acute exacerbation, and an increased risk of death of 80% for patients with two moderate to severe acute exacerbations. At present, there is a lack of specific quantitative indicators for the diagnosis and severity assessment of acute exacerbation of chronic obstructive pulmonary disease (COPD), mainly based on the patient’s symptoms, signs, and the doctor’s judgment. Therefore, infectious inflammatory markers are crucial for the diagnosis and treatment of AECOPD. This article provides a review of recent research on biomarkers for COPD.
文章引用：王乌云, 毛广泽, 佟淑平. 慢性阻塞性肺疾病与相关生物标志物研究进展[J]. 临床个性化医学, 2024, 3(4): 1286-1292. https://doi.org/10.12677/jcpm.2024.34182

参考文献

[1] 杨国林, 易何娟. 血清CRP、PCT、IL-17对慢性阻塞性肺疾病稳定期患者急性发作的预测作用[J]. 检验医学与临床, 2024, 21(7): 999-1002.
[2] Carter, J.A. and Burke, H.B. (2021) CRP-guided Antibiotic Therapy for Acute COPD Exacerbation: A Randomized Control Trial. Journal of General Internal Medicine, 36, 2194-2196. [Google Scholar] [CrossRef] [PubMed]
[3] Nikolakopoulou, S., Hillas, G., Perrea, D., Tentolouris, N., Loukides, S., Kostikas, K., et al. (2013) Serum Angiopoietin-2 and CRP Levels during COPD Exacerbations. COPD: Journal of Chronic Obstructive Pulmonary Disease, 11, 46-51. [Google Scholar] [CrossRef] [PubMed]
[4] 马群. 血清PCT、hs-CRP检肺急性加重期患者预后的影响[J]. 航空航天医学杂志, 2019, 30(1): 56+80.
[5] 李璐, 鹿敏. 血清相关细胞因子水平变化与COPD肺功能的相关性及临床意义[J]. 罕少疾病杂志, 2024, 31(7): 37-39.
[6] Ceylan, O., Ucgun, I., et al. (2015) The Role of Serum Procalcitonin and CRP Levels in Determining of Etiology and Outcome in Acute Exacerbations of COPD. Intensive Care Medicine Experimental, 3, A796.
[7] Broekhuizen, R. (2005) Raised CRP Levels Mark Metabolic and Functional Impairment in Advanced COPD. Thorax, 61, 17-22. [Google Scholar] [CrossRef] [PubMed]
[8] Yao, X., Feng, W., Gong, Z. and Li, X. (2024) Clinical Significance of Long Non-Coding RNA SNHG5 in the Diagnosis and Prognosis of Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease, 21, Article 2363630. [Google Scholar] [CrossRef] [PubMed]
[9] Tan, B.K., Chen, J., Hu, J., Amar, O., Mattu, H.S., Ramanjaneya, M., et al. (2014) Circulatory Changes of the Novel Adipokine Adipolin/CTRP12 in Response to Metformin Treatment and an Oral Glucose Challenge in Humans. Clinical Endocrinology, 81, 841-846. [Google Scholar] [CrossRef] [PubMed]
[10] Aslani, M.R., Amani, M., Moghadas, F. and Ghobadi, H. (2022) Adipolin and IL-6 Serum Levels in Chronic Obstructive Pulmonary Disease. Advances in Respiratory Medicine, 90, 391-398. [Google Scholar] [CrossRef] [PubMed]
[11] Babapour, B., Doustkami, H., Avesta, L., Moradi, A., Saadat, S., Piralaei, K., et al. (2020) Correlation of Serum Adipolin with Epicardial Fat Thickness and Severity of Coronary Artery Diseases in Acute Myocardial Infarction and Stable Angina Pectoris Patients. Medical Principles and Practice, 30, 52-61. [Google Scholar] [CrossRef] [PubMed]
[12] Celli, B.R., Locantore, N., Yates, J., et al. (2012) Inflammatory Biomarkers Improve Clinical Prediction of Mortality in COPD. American Journal of Respiratory and Critical Care Medicine, 185, 1065-1072.
[13] He, J.Q., Foreman, M.G., Shumansky, K., et al. (2009) Associations of IL6Polymorphisms with Lung Function Decline and COPD. Thorax, 64, 698-704.
[14] Yanbaeva, D.G., Dentener, M.A., Spruit, M.A., Houwing-Duistermaat, J.J., Kotz, D., Passos, V.L., et al. (2009) IL6 and Crphaplotypes Are Associated with COPD Risk and Systemic Inflammation: A Case-Control Study. BMC Medical Genetics, 10, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[15] Watkins, L.R., Chavez, R.A., Landry, R., Fry, M., Green-Fulgham, S.M., Coulson, J.D., et al. (2020) Targeted Interleukin-10 Plasmid DNA Therapy in the Treatment of Osteoarthritis: Toxicology and Pain Efficacy Assessments. Brain, Behavior, and Immunity, 90, 155-166. [Google Scholar] [CrossRef] [PubMed]
[16] Uchida, A.M., Boden, E.K., James, E.A., Shows, D.M., Konecny, A.J. and Lord, J.D. (2020) Escherichia Coli-Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn’s Disease. Cellular and Molecular Gastroenterology and Hepatology, 10, 507-526. [Google Scholar] [CrossRef] [PubMed]
[17] Isac, L. and Jiquan, S. (2019) Interleukin 10 Promotor Gene Polymorphism in the Pathogenesis of Psoriasis. Acta Dermatovenerologica Alpina Pannonica et Adriatica, 28, 119-123. [Google Scholar] [CrossRef] 
[18] Silva, B.S.A., Lira, F.S., Ramos, D., Uzeloto, J.S., Rossi, F.E., Freire, A.P.C.F., et al. (2018) Severity of COPD and Its Relationship with Il-10. Cytokine, 106, 95-100. [Google Scholar] [CrossRef] [PubMed]
[19] Jacobs, M., Verschraegen, S., Salhi, B., Anckaert, J., Mestdagh, P., Brusselle, G.G., et al. (2022) IL-10 Producing Regulatory B Cells Are Decreased in Blood from Smokers and COPD Patients. Respiratory Research, 23, Article No. 287. [Google Scholar] [CrossRef] [PubMed]
[20] Xiao, D., Chen, Z., Wu, S., et al. (2020) Prevalence and Risk Factors of Small Airway Dysfunction, and Association with Smoking, in China: Findings from a National Cross⁃Sectional Study. The Lancet Respiratory Medicine, 8, 1081-1093.
[21] 黄懿洁, 艾涛. 小气道功能障碍的测定及其临床意义[J]. 中国实用儿科杂志, 2021, 36(6): 420-425.
[22] 于易琼, 丁震, 徐康, 等. 血清白介素-10与慢阻肺患者肺功能之间的关系[J]. 临床肺科杂志, 2023, 28(11): 1692-1696.
[23] Trivella, D.B.B., Ferreira-Júnior, J.R., Dumoutier, L., Renauld, J. and Polikarpov, I. (2010) Structure and Function of Interleukin-22 and Other Members of the Interleukin-10 Family. Cellular and Molecular Life Sciences, 67, 2909-2935. [Google Scholar] [CrossRef] [PubMed]
[24] Guo, H. and Topham, D.J. (2010) Interleukin-22(IL-22) Production by Pulmonary Natural Killer Cells and the Potential Role of IL-22during Primary Influenza Virus Infection. Journal of Virology, 84, 7750-7759.
[25] 徐影. COPD患者检测IL-22, hs-CRP和PA的临床意义[J]. 临床和实验医学杂志, 2011, 10(16): 1235-1236.
[26] Tamimi, A., Serdarevic, D. and Hanania, N.A. (2012) The Effects of Cigarette Smoke on Airway Inflammation in Asthma and COPD: Therapeutic Implications. Respiratory Medicine, 106, 319-328. [Google Scholar] [CrossRef] [PubMed]
[27] Barnes, P.J., Ito, K. and Adcock, I.M. (2004) Corticosteroid Resistance in Chronic Obstructive Pulmonary Disease: Inactivation of Histone Deacetylase. The Lancet, 363, 731-733. [Google Scholar] [CrossRef] [PubMed]
[28] 李江涛, 王媛, 王亮, 等. 血清HDAC2和SP-D对经鼻高流量氧疗治疗慢性阻塞性肺疾病急性加重期合并轻中度Ⅱ型呼吸衰竭患者预后的诊断价值[J]. 中国医药导报, 2022, 19(10): 25-29.
[29] 贾博, 张少华, 刘建军. 老年COPD患者CD83、IL-17、SP-D、HDAC2 mRNA水平变化及其临床意义[J]. 中国老年学杂志, 2019, 39(4): 823-825.
[30] Sorensen, G.L. (2018) Surfactant Protein D in Respiratory and Non-Respiratory Diseases. Frontiers in Medicine, 5, Article 18. [Google Scholar] [CrossRef] [PubMed]
[31] 陈文静. SP-D在慢性阻塞性肺疾病患者血清中的表达及临床意义[D]: [硕士学位论文]. 长春: 吉林大学, 2023.
[32] Orgeig, S., Hiemstra, P.S., Veldhuizen, E.J.A., Casals, C., Clark, H.W., Haczku, A., et al. (2010) Recent Advances in Alveolar Biology: Evolution and Function of Alveolar Proteins. Respiratory Physiology & Neurobiology, 173, S43-S54. [Google Scholar] [CrossRef] [PubMed]